Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
The AHA urge leaders of the House Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies to consider the potential effect their health care funding decisions for fiscal year 2022 will have on hospitals’ ability to care for their patients and communities…
The AHA shares with Senate and House leaders the association’s recommendations for infrastructure investments that should be included in an upcoming legislative package to ensure hospitals and health systems are fully equipped to care for their communities now and into the future, as well as…
The AHA and five other health care organizations sent the attached letter to HHS Secretary Becerra urging him to stop the actions of six drug companies that are denying 340B discounts on prescription drugs sold to hospitals treating a large percentage of low-income and rural Americans.
The AHA appreciates the recent flexibility around survey activities provided by the Centers for Medicare & Medicaid Services (CMS).
In a letter to Representatives Terri Sewell and Vern Buchanan the AHA expresses support of the Resetting the Impact Act (TRIA) of 2021.
Fourteen organizations, including the AHA, urge the Department of Health and Human Services to extend the Next Generation Accountable Care Organization model through 2022, and create a permanent full-risk ACO option based on it for the future.
AHA voices support for Biden nominee, Andrea Palm, for HHS Deputy Secretary.
AHA voices support for Biden Nominee, Chiquita Brooks-LaSure, for CMS Administrator.
AHA shares initial recommendations for priorities to include in infrastructure legislative package.
The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”